Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04421716 · ClinicalTrials.gov registry record · Early Phase 1
Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid
A Early Phase 1 study of Bioavailability of Phytonutrients, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04421716 is a Early Phase 1 study of Bioavailability of Phytonutrients that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04421716, a Early Phase 1 study of Bioavailability of Phytonutrients, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this research is to investigate the bioavailability of curcumin (CURC) and ursolic acid (UA) in a phase I clinical trial in healthy men and obtain biological material for bioavailability analysis.
Conditions Studied
Interventions
- DRUG Curcumin
- DRUG Ursolic Acid
Study Locations (1)
Texas
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2021-04-16 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04421716
The ClinicalTrials.gov registry entry for NCT04421716 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bioavailability of Phytonutrients appearing as the primary indexed condition, and to 2 interventions - of which Curcumin is the first listed.
NCT04421716 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04421716 about?
NCT04421716 is a clinical study titled "Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid". The primary objective of this research is to investigate the bioavailability of curcumin (CURC) and ursolic acid (UA) in a phase I clinical trial in healthy men and obtain biological material for bioavailability analysis.
What is the current status of trial NCT04421716?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2020-10-20. Estimated completion is 2021-04-16.
What conditions does trial NCT04421716 study?
This clinical trial studies the following conditions: Bioavailability of Phytonutrients.
What interventions are being tested in trial NCT04421716?
The interventions under investigation include: Curcumin (DRUG), Ursolic Acid (DRUG).
Who is sponsoring clinical trial NCT04421716?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04421716 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.